Skip to main content

Table 1 Patients characteristics (n = 47)

From: Use of percutaneous microwave ablation for the treatment of bone tumors: a retrospective study of clinical outcomes in 47 patients

Characteristics

No. of patients

Percentage (%)

Age (years)

Mean±SD (years)

43.1±16.6

Range

8–71

Gender

Male

22

46.8%

Female

25

53.2%

VAS score on admission

<6

20

42.6%

≥6

27

57.4%

Tumor pathology

Benign bone tumors (n = 26)

Osteoid osteoma

6

23.1%

Osteoblastoma

5

19.2%

Enchondroma

12

46.2%

Osteofibrous dysplasia

2

7.7%

Nonossifying fibroma

1

3.8%

Malignant bone tumors (n = 21)

Bone metastases

16

76.2%

Multiple myeloma

5

23.8%

Lesion location

Spine or sacrum

15

31.9%

Upper extremity

6

12.8%

Lower extremity

17

36.2%

Pelvis

9

19.1%

Surgical management

MWA

14

29.8%

MWA+BC

18

38.3%

Endoscopic MWA+IAB/BC

15

31.9%

Follow-up (months)

Mean±SD (months)

4.8±1.6

Range

2–9

  1. VAS Visual analog scale, MWA Microwave ablation, BC Bone cement, IAB Injectable artificial bone